Related Experiment Video
Updated: Jun 24, 2026
11:15
Stereotactic Adoptive Transfer of Cytotoxic Immune Cells in Murine Models of Orthotopic Human Glioblastoma Multiforme Xenografts
Published on: September 1, 2018
Immunotherapeutic approaches for glioma
Hideho Okada1, Gary Kohanbash, Xinmei Zhu
1Brain Tumor Program, University of Pittsburgh Cancer Institute, Pittsburgh, PA 15213, USA. okadah@upmc.edu
Critical Reviews in Immunology
|April 8, 2009
Summary
Understanding the central nervous system (CNS) tumor immunology is key for developing effective glioma immunotherapies. This review explores advances and challenges in CNS immunology to improve glioma treatment strategies.
Area of Science:
- Neuroimmunology
- Oncology
- Immunotherapy
Background:
- The central nervous system (CNS) is an immunologically privileged site, presenting unique challenges for immunotherapy.
- Gliomas exhibit immune escape mechanisms that hinder effective treatment.
- Recent technological and immunological advancements offer new avenues for glioma immunotherapy.
Purpose of the Study:
- To review current understanding of CNS and CNS tumor immunology.
- To summarize advances in passive and active immunotherapy for gliomas.
- To explore novel immunotherapy strategies with potential for glioma treatment.
Main Methods:
- Literature review of recent advances in CNS immunology and glioma immunotherapy.
- Analysis of factors contributing to glioma immune escape.
- Evaluation of early-phase clinical trial data for glioma immunotherapies.
- Assessment of novel immunotherapies tested in non-CNS tumors for potential glioma application.
Main Results:
- Recent discoveries highlight novel mechanisms to enhance immunotherapy efficacy in the CNS.
- Early-phase clinical trials provide valuable lessons for glioma immunotherapy development.
- Strategies from other tumor types show promise for glioma treatment.
- Combination therapies may offer significant clinical benefit for glioma patients.
Conclusions:
- A comprehensive understanding of CNS immunology is crucial for effective glioma immunotherapy.
- Overcoming immune evasion and optimizing delivery are key challenges.
- Novel and combination immunotherapy approaches hold significant promise for improving patient outcomes in glioma.
Related Concept Videos
01:27Tumor Immunotherapy
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...